Search for Clinical Trials
Study Product: CSL312 (Garadacimab, factor XIIa antagonist monoclonal antibody) for treatment of idiopathic pulmonary fibrosis (IPF).
Inclusion…
This study aims to understand the impact of misophonia on children ages 5-20 and families. Eligible participants will complete a 90-minute visit with…
IgA is a defense protein that lines the gut and can be measured in blood. IgA changes how much and what types of bacteria are in the gut. The amount…
Introduction: Thanks to advances in early detection and treatment, people are living longer and fuller lives after being diagnosed with head and neck…
Study To Evaluate Perioperative Circulating Tumor DNA As A Prognostic Biomarker In Patients Undergoing Neoadjuvant Therapy For Resectable Non-Small…
Objective:
The primary objective is to determine lung cancer–specific survival at 5 years among patients undergoing active surveillance for GGOs.…
Primary objectives:
To compare recurrence-free survival in patients with "low risk" lung-limited mCRC undergoing pulmonary metastasectomy with or…
RM-493-034: A 2-Stage (Open-Label Run-In Followed by Randomized Withdrawal), Double-Blind, Placebo-Controlled, Phase 2 Study of Setmelanotide In…
Investigators have previously used this sort of therapy to treat Hodgkin or non-Hodgkin lymphoma that is associated with the virus that causes…
Long Term Extension Trial Of Setmelanotide (RM-493) For Patients Who Have Completed A Trial Of Setmelanotide For The Treatment Of Obesity Associated…
